IBA SELECTS ELEKTA SOFTWARE FOR KEY PROTON THERAPY SITE IN PRAGUE

IBA SELECTS ELEKTA SOFTWARE FOR KEY PROTON THERAPY SITE IN PRAGUE

Elekta will provide treatment planning and information management systems for a
major Proton Therapy facility in Prague, Czech Republic. The software solutions
will facilitate the highest quality of patient care and lead to improved
clinical efficiency.

Elekta is a key provider of software solutions in the Proton Therapy market, as
evidenced by its inclusion in an international Proton Therapy site, the Proton
Therapy Center Czech S.R.O. in Prague.

The Center will be equipped with MOSAIQ®, an intuitive, yet powerful oncology
information system that increases process efficiency, allows real-time access to
clinical information and facilitates the highest quality patient care. 

“The workflow-centric approach of MOSAIQ will lead to increased patient comfort
during the entire treatment process, as well as a high level of optimization of
staffing activities on a daily basis”, says Benoit Raskin, Executive Director of
Particle Oncology Solutions Integration at Ion Beam Applications (IBA), whose
mission is to fight cancer through solutions for cancer diagnosis and therapy.

The Center will also be equipped with XiO®, a comprehensive system that combines
the latest tools and most robust dose calculation algorithms to generate quick,
accurate treatment plans. Developed more than a decade ago, XiO for Proton
Therapy is in clinical use at more proton facilities than any other commercial
vendor with a similar product.

Mr. Raskin says XiO delivers a comprehensive planning functionality that
addresses all of IBA's clinical needs. “It will support all proton treatment
modalities: Scattered or Wobbled beams, Spot Scanning and Ocular treatment.
XiO's powerful automated planning tools reduce planning time and increase
clinical efficiency, in even the most demanding environments.”

MOSAIQ, as well as XiO treatment planning software from Elekta are designed to
support different types of radiation systems and modalities, including Intensity
Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT). This
is in keeping with Elekta's long-standing history of supporting multiple vendors
and open systems. 

The combination of IBA's leadership in proven, reliable Proton Therapy equipment
and Elekta's pioneering oncology software solutions is more than an integrated
concept, says Mr. Raskin. “It's the best of two worlds, united in a common
strategy for excellent patient care in radiation oncology.”

Mr. Raskin says the oncology market is turning toward the benefits of Proton
Therapy. “The strength of this therapy - great dose control and sparing of
normal tissue - can enhance and increase the effectiveness of radiation
therapy.”

"Elekta is delighted to be collaborating with IBA on this exciting opportunity,”
says Stewart Pegrum, Director Elekta Particle Therapy. “Our common vision to
provide optimized solutions for particle therapy is paramount to our continued
goal of delivering the best in patient care."

For further information, please contact:

Stina Thorman, Investor Relations, Elekta AB
Tel: +46 8 587 254 37 +46 70 778 6010, e-mail: stina.thorman@elekta.com

Michelle Lee, Director, Marketing Services, Elekta Inc. 
Tel: +1 770-670-2447, e-mail: michelle.lee@elekta.com

About Elekta

Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated state of the art tools and treatment planning systems for
radiation therapy and radiosurgery, as well as workflow enhancing software
systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and
resource-efficient solutions that offer confidence to both healthcare providers
and patients, Elekta aims to improve, prolong and even save patient lives,
making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000
hospitals globally, and every day more than 100,000 patients receive diagnosis,
treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is
located in Stockholm, Sweden, and the company is listed on the Nordic Exchange
under the ticker EKTAb. For more information about Elekta, please visit
www.elekta.com.